• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用氨甲酰甲胆碱麻醉后条件反射恢复的加速情况]

[Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].

作者信息

Prozorovskiĭ V B, Iudkina N I

出版信息

Anesteziol Reanimatol. 1991 Jan-Feb(1):25-6.

PMID:1862957
Abstract

The effect of anesthesia with ketamine (80 mg/kg, intraperitoneally) combined with phenazepam (0.5 mg/kg, subcutaneously) on the reproduction of an elaborated active avoidance reflex in automated reflexometer has been studied on random bred white rats. In has been shown that during 3 hours after the animal is taken out of the lateral position the degree of its learning is significantly lowered and does not return to baseline even a day later. Intramuscular administration of a new cholinesterase inhibitor aminostigmine right after the end of anesthesia restores the disrupted reflex in 3 hours. The optimal antistigmine dose is 0.015 mg/kg, which corresponds to a therapeutic human dose.

摘要

在随机繁殖的白色大鼠身上,研究了氯胺酮(80毫克/千克,腹腔注射)联合非那西泮(0.5毫克/千克,皮下注射)麻醉对自动反射计中精细主动回避反射重现的影响。结果表明,动物从侧卧姿势取出后的3小时内,其学习程度显著降低,甚至一天后也未恢复到基线水平。麻醉结束后立即肌肉注射一种新型胆碱酯酶抑制剂氨基新斯的明,3小时后可恢复被打乱的反射。最佳抗胆碱酯酶剂量为0.015毫克/千克,这相当于人类治疗剂量。

相似文献

1
[Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].[使用氨甲酰甲胆碱麻醉后条件反射恢复的加速情况]
Anesteziol Reanimatol. 1991 Jan-Feb(1):25-6.
2
[New data on the pharmacokinetics of aminostigmine].[关于氨甲酰甲胆碱药代动力学的新数据]
Eksp Klin Farmakol. 1998 Sep-Oct;61(5):46-9.
3
[The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].[抗胆碱药与一种新型可逆性胆碱酯酶抑制剂氨甲酰甲胆碱相互作用的毒理学特征]
Eksp Klin Farmakol. 1995 Sep-Oct;58(5):57-61.
4
[Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].氨基新斯的明作为一种胆碱酯酶抑制剂及用于治疗胆碱能阻滞剂中毒的药物
Eksp Klin Farmakol. 1994 Sep-Oct;57(5):13-5.
5
[The pharmacological characteristics of the new anticholinesterase drug aminostigmine].[新型抗胆碱酯酶药物氨甲酰甲胆碱的药理学特性]
Eksp Klin Farmakol. 1992 Jan-Feb;55(1):13-6.
6
[Biochemical characteristics of aminostigmine--a new anticholinesterase agent].[新型抗胆碱酯酶药物氨基新斯的明的生化特性]
Biokhimiia. 1996 Apr;61(4):690-6.
7
[The comparative clinico-experimental characteristics of aminostigmine and galanthamine used for treating poisonings by choline-blocking substances].[用于治疗胆碱阻断物质中毒的氨甲酰甲胆碱和加兰他敏的临床实验对比特征]
Eksp Klin Farmakol. 1996 Jan-Feb;59(1):64-7.
8
[Bizerine: new anticholinesterase drug with selective gastrointestinal action].[比泽林:具有选择性胃肠道作用的新型抗胆碱酯酶药物]
Eksp Klin Farmakol. 2010 Aug;73(8):14-6.
9
[Protection of mice by carbamates cholinesterase inhibitors against poisoning by armin and its dependence on certain physico-chemical indicators].[氨基甲酸酯类胆碱酯酶抑制剂对小鼠的保护作用及其对某些理化指标的依赖性]
Vopr Med Khim. 1999 Nov-Dec;45(6):525-9.
10
[Aminostigmine-a novel drug against home poisoning].[氨基新斯的明——一种治疗家庭中毒的新型药物]
Klin Med (Mosk). 1996;74(8):58-61.